04/14/2026
The apolipoprotein E ε3 Christchurch variant provides remarkable resilience against AD which extends to the periphery where ‘lipid-loaded’ extracellular vesicles stabilize the blood–brain barrier.
The apolipoprotein E ε3 Christchurch variant provides remarkable resilience against Alzheimer disease by limiting tau propagation and suppressing neuroinflammation. New research reveals that this protection extends to the periphery, where ‘lipid-loaded’ extracellular vesicles stabilize the bloo...